BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28865918)

  • 1. Extraparotidal low grade follicular lymphoma associated with primary Sjögren's syndrome.
    Gómez-Rubio J; Bárcena-Atalaya AB; Ruiz-Irastorza G
    Med Clin (Barc); 2018 Mar; 150(5):204-205. PubMed ID: 28865918
    [No Abstract]   [Full Text] [Related]  

  • 2. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
    Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of mantle-zone lymphoma with salivary gland swelling as the initial manifestation].
    Mizorogi F; Nakata T; Satoi S; Kajiyama K; Ogasawara H; Tsuiki S; Tanaka T; Horiguchi M; Takaki K
    Nihon Naika Gakkai Zasshi; 1987 Oct; 76(10):1559-64. PubMed ID: 3437187
    [No Abstract]   [Full Text] [Related]  

  • 4. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
    Chan TS; Khong PL; Kwong YL
    Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary prophylaxis of an acute coronary syndrome during rituximab infusion.
    Triguero Moreno A; Gual Capllonch F; Sancho Cía JM
    Med Clin (Barc); 2020 Jan; 154(2):69-70. PubMed ID: 31178296
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival lymphoma in right eye: Case report.
    Parada-Vásquez RH; Lomas-Guaman VE; León-Roldán CR
    Arch Soc Esp Oftalmol; 2017 Feb; 92(2):78-81. PubMed ID: 27388111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose therapy for follicular lymphoma revisited: not if, but when?
    Lister TA
    J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites.
    Hiroshima Y; Tajima K; Shiono Y; Suzuki I; Kouno K; Yamamoto M; Kato Y; Kato T
    Ann Hematol; 2012 Sep; 91(9):1499-500. PubMed ID: 22281990
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma.
    Carbone J; Perez-Fernandez R; Muñoz A; Sabin P; Carreño L; Fernandez-Cruz E
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):80-4. PubMed ID: 18270861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium-67 scintigraphic findings in a patient with breast lymphoma complicated with Sjögren syndrome.
    Yoshimura M; Koizumi K; Satani K; Kakizaki D; Kawanishi Y; Ohyashiki K; Abe K
    Ann Nucl Med; 2000 Jun; 14(3):227-9. PubMed ID: 10921490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.
    Hiddemann W; Barbui AM; Canales MA; Cannell PK; Collins GP; Dürig J; Forstpointner R; Herold M; Hertzberg M; Klanova M; Radford J; Seymour JF; Tobinai K; Trotman J; Burciu A; Fingerle-Rowson G; Wolbers M; Nielsen T; Marcus RE
    J Clin Oncol; 2018 Aug; 36(23):2395-2404. PubMed ID: 29856692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
    [No Abstract]   [Full Text] [Related]  

  • 14. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma in Sjögren's syndrome showing only the LIP pattern radiologically.
    Watanabe Y; Koyama S; Miwa C; Okuda S; Kanai Y; Tetsuka K; Nokubi M; Dobashi Y; Kawabata Y; Kanda Y; Endo S
    Intern Med; 2012; 51(5):491-5. PubMed ID: 22382565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma.
    Bravo-Perez C; Pajares I; Muiña B; Escobar H; Amigo ML; Garcia-Malo MD; Garcia J; Rodriguez-Pinilla SM; Piris MA; Ortuño FJ
    Ann Hematol; 2020 Feb; 99(2):391-393. PubMed ID: 31858188
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas.
    Domingo-Domènech E; González-Barca E; Estany C; Sureda A; Besalduch J; Fernández de Sevilla A
    Haematologica; 2002 Nov; 87(11):1229-30. PubMed ID: 12414357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era.
    Mustafa Ali M; Rybicki L; Nomani L; Rouphail B; Dean RM; Hill BT; Jagadeesh D; Pohlman B; Hsi ED; Smith MR
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):797-803. PubMed ID: 28789937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sjögren's syndrome complicated by thymoma].
    Terashima M; Nishimura Y; Kageshita T; Kajiura Y; Nakata H; Matsubara M; Iwai Y; Yokoyama M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34(12):1369-74. PubMed ID: 9022322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
    Jäger G; Quehenberger F; Linkesch W; Neumeister P
    Eur J Haematol; 2007 May; 78(5):453-5. PubMed ID: 17419745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.